[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU1711599A - Prodrugs of lobucavir and methods of use - Google Patents

Prodrugs of lobucavir and methods of use

Info

Publication number
AU1711599A
AU1711599A AU17115/99A AU1711599A AU1711599A AU 1711599 A AU1711599 A AU 1711599A AU 17115/99 A AU17115/99 A AU 17115/99A AU 1711599 A AU1711599 A AU 1711599A AU 1711599 A AU1711599 A AU 1711599A
Authority
AU
Australia
Prior art keywords
lobucavir
prodrugs
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17115/99A
Inventor
Natesan Murugesan
Robert Zahler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU1711599A publication Critical patent/AU1711599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU17115/99A 1997-12-19 1998-12-04 Prodrugs of lobucavir and methods of use Abandoned AU1711599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6834197P 1997-12-19 1997-12-19
US60068341 1997-12-19
PCT/US1998/025815 WO1999032490A1 (en) 1997-12-19 1998-12-04 Prodrugs of lobucavir and methods of use

Publications (1)

Publication Number Publication Date
AU1711599A true AU1711599A (en) 1999-07-12

Family

ID=22081942

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17115/99A Abandoned AU1711599A (en) 1997-12-19 1998-12-04 Prodrugs of lobucavir and methods of use

Country Status (5)

Country Link
AR (1) AR014135A1 (en)
AU (1) AU1711599A (en)
PE (1) PE20000051A1 (en)
UY (1) UY25311A1 (en)
WO (1) WO1999032490A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820416D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
CN113939504A (en) * 2018-12-12 2022-01-14 詹森生物制药有限公司 Cyclobutyl nucleoside analogues as antiviral agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126345A (en) * 1988-03-30 1992-06-30 E. R. Squibb & Sons, Inc. Bis (hydroxymethyl) cyclobutyl triazolopyrimidines
US5153352A (en) * 1988-10-25 1992-10-06 Bristol-Myers Squibb Company Process for preparation of intermediates of carbocyclic nucleoside analogs
DE4311801A1 (en) * 1993-04-09 1994-10-13 Hoechst Ag New carboxylic acid esters of 2-amino-7- (1,3-dihydroxy-2-propoxymethyl) purine, their preparation and their use
GB9320316D0 (en) * 1993-10-01 1993-11-17 Smithkline Beecham Plc Pharmaceuticals
TW282470B (en) * 1993-11-18 1996-08-01 Ajinomoto Kk
PE32296A1 (en) * 1994-07-28 1996-08-07 Hoffmann La Roche L-MONOVALINE ESTER DERIVED FROM 2- (2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-IL) METOXI-1,3-PROPANDIOL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives

Also Published As

Publication number Publication date
AR014135A1 (en) 2001-02-07
PE20000051A1 (en) 2000-04-23
WO1999032490A1 (en) 1999-07-01
UY25311A1 (en) 2000-12-29

Similar Documents

Publication Publication Date Title
AU9790198A (en) Compounds and methods
AU6709596A (en) Amide compounds and use of the same
AU8169498A (en) Backpack assembly and method of use
AU7710198A (en) Single pass lead and method of use
AU6079598A (en) Additive preparation and method of use thereof
AU1616499A (en) Chemokine variants and methods of use
AU9781998A (en) Huchordin and uses thereof
AU1387399A (en) Probucol esters and uses thereof
AU7129098A (en) Synthesis and use of alpha-ketoamide derivatives and arrays
AU6695398A (en) Immunoadhesins and methods of production and use thereof
AU8662198A (en) Activated forms of notch and methods based thereon
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU3118297A (en) Sok-1 and methods of use
AU4224096A (en) Use of phenylcyclohexylcarboxamides
HUP9800146A3 (en) Thalidomide-derivatives and use of them
AU1933297A (en) Manufacture of elongate members
IL134210A0 (en) Use of transcription factor brn-3a
AUPO695497A0 (en) End of line pipeliner
AUPM967194A0 (en) Surface modification of kaolinite
AU8333998A (en) New use of nociceptin
AU1711599A (en) Prodrugs of lobucavir and methods of use
AU7135598A (en) Synthesis and use of biased arrays
AU6084598A (en) Antibiotic-ligand conjugates and methods of use thereof
AU2595297A (en) Use of aminoalkylcarboxylic derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase